Current status of clinically available bioresorbable scaffolds in percutaneous coronary interventions

Drug-eluting stents (DES) are widely used as first choice devices in percutaneous coronary interventions. However, certain concerns are associated with the use of DES, i.e. delayed arterial healing with a subsequent risk of neo-atherosclerosis, late stent thrombosis and hypersensitivity reactions to...

Descripción completa

Detalles Bibliográficos
Autores principales: Felix, Cordula, Everaert, Bert, Diletti, Roberto, Van Mieghem, Nicolas, Daemen, Joost, Valgimigli, Marco, de Jaegere, Peter P., Zijlstra, Felix, Regar, Evelyn, Simsek, Cihan, Onuma, Yoshinobu, van Geuns, Robert-Jan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352158/
https://www.ncbi.nlm.nih.gov/pubmed/25626697
http://dx.doi.org/10.1007/s12471-015-0652-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352158/
https://www.ncbi.nlm.nih.gov/pubmed/25626697
http://dx.doi.org/10.1007/s12471-015-0652-2

Ejemplares similares